Advertisement
Singapore markets closed
  • Straits Times Index

    3,338.94
    -9.93 (-0.30%)
     
  • S&P 500

    5,264.34
    -19.06 (-0.36%)
     
  • Dow

    38,522.75
    -48.28 (-0.13%)
     
  • Nasdaq

    16,770.08
    -58.59 (-0.35%)
     
  • Bitcoin USD

    70,279.95
    +1,041.35 (+1.50%)
     
  • CMC Crypto 200

    1,463.40
    +16.25 (+1.12%)
     
  • FTSE 100

    8,233.46
    -29.29 (-0.35%)
     
  • Gold

    2,347.90
    -21.40 (-0.90%)
     
  • Crude Oil

    73.09
    -1.13 (-1.52%)
     
  • 10-Yr Bond

    4.3470
    -0.0550 (-1.25%)
     
  • Nikkei

    38,837.46
    -85.54 (-0.22%)
     
  • Hang Seng

    18,444.11
    +41.11 (+0.22%)
     
  • FTSE Bursa Malaysia

    1,615.40
    +18.72 (+1.17%)
     
  • Jakarta Composite Index

    7,099.31
    +63.12 (+0.90%)
     
  • PSE Index

    6,386.42
    -84.32 (-1.30%)
     

23andMe CEO Wojcicki considering taking firm private, filing shows

April 17 (Reuters) - 23andMe co-founder and chief executive Anne Wojcicki is considering making an offer to buy the genetics testing company in a potential go-private transaction, a regulatory filing on late Wednesday showed.

Last week, Wojcicki notified members of the board's special committee that she is considering a potential go-private transaction for 23andMe and indicated that she would begin speaking to partners and financing sources.

23andMe declined to comment on the filing and Wojcicki did not immediately respond to a Reuters' request for comment.

Last year, the company informed several customers of a data breach in the "DNA Relatives" feature that allowed them to compare ancestry information with users worldwide.

ADVERTISEMENT

23andMe, best known for its saliva-based test kits that offer users a glimpse into their genetic ancestry went public in 2021 through a blank-check firm, backed by Virgin Group founder Richard Branson, in a deal that valued the merged entity at $3.5 billion.

(Reporting by Mrinmay Dey in Bengaluru; Editing by Eileen Soreng)